Three colleagues collaborating at a desk with laptops and documents, seen from above

MDR Compliance for Small Medical Device Manufacturers

Practical regulatory consulting to bring your Class I, IIa and IIb devices to the European market — without the overhead of a large consultancy.

MDR 2017/745 · ISO 13485 · ISO 14971

The challenge

Navigating MDR 2017/745 Shouldn’t Consume Your Resources

Regulation (EU) 2017/745 sets a high bar for every device on the EU market. Meeting it with a small team is a matter of method, not headcount.

A complex regulation

Step-by-step guidance: a clear view of which requirements apply to your device — and which don’t.

A limited budget

Tailored packages: fixed-price project quotes and monthly retainers sized for small teams. No hidden fees.

Tight timelines

A focused approach: work on what moves your device toward the market, nothing else.

Article 15

Article 15 Requires a PRRC. Hiring One Isn’t Your Only Option.

Article 15 of MDR 2017/745 requires every manufacturer to have a Person Responsible for Regulatory Compliance (PRRC). Micro and small enterprises are not required to hire one: they may appoint an external PRRC, provided that person is permanently and continuously at their disposal.

I serve as external PRRC for manufacturers and authorised representatives — qualified under Article 15 from day one.

The PRRC appointment does not transfer your legal responsibility as manufacturer. You remain solely responsible for the conformity of your devices.

Services

Compliance Projects

Defined scope, fixed-price quote, concrete deliverables. Six areas where your device moves forward.

MDR Compliance Consulting

Gap analysis, classification support and a regulatory roadmap: know exactly where your device stands, and what is left before CE marking.

Learn More →

Technical Documentation

Technical files structured to Annexes II and III of MDR 2017/745, ready for Notified Body review.

Learn More →

ISO 13485 Implementation

A quality management system (QMS) built for your size: documented, operational, audit-ready.

Learn More →

Risk Management (ISO 14971)

A complete risk management file: hazard identification, control measures, residual-risk evaluation and benefit-risk rationale.

Learn More →

EUDAMED Registration

Actor registration, device registration and UDI (Unique Device Identification) data in EUDAMED — completed, verified and maintained.

Learn More →

Post-Market Surveillance

Post-Market Surveillance (PMS) plans, vigilance procedures and Periodic Safety Update Report (PSUR) preparation that keep you compliant after launch.

Learn More →

The process

How It Works

1 · Free initial assessment

30 minutes on your device, your market and your current documentation.

2 · Gap analysis & roadmap

What is missing, what comes first, and realistic milestones.

3 · Implementation support

Documentation, QMS, risk management, registrations.

4 · Certification & market access

Support through conformity assessment to CE marking.

Typical timeline: 3–9 months, depending on device class, complexity and existing documentation.

The difference

Why Complimed

Built for small manufacturers

I work with teams under 50 people and design every deliverable around their constraints.

Pragmatic, not bureaucratic

Documentation that serves compliance, not paperwork for its own sake.

Transparent pricing

Fixed-price project quotes and monthly PRRC retainers. The model is public; the figure depends on your device portfolio. No hourly billing, no hidden fees.

From concept to market

One qualified contact through the whole journey, from classification to post-market.

Small manufacturers

Under 50 Employees? The Rules Are Written With You in Mind.

Micro and small enterprises — fewer than 50 employees and annual turnover or balance sheet total not exceeding €10 million (Recommendation 2003/361/EC) — may outsource the PRRC role instead of hiring. See what else changes for you.

What this means for small manufacturers →

Ready to Start?

Free 30-minute initial consultation · Response within 24 hours · No obligation

Regulatory information last reviewed: 10 August 2026